Safety and Discontinuation Rate of Dimethyl Fumarate (Zadiva(®)) in Patients with Multiple Sclerosis: An Observational Retrospective Study

Background: This study evaluates the real-world safety and discontinuation rate of Zadiva(®) (generic product of dimethyl fumarate (DMF)) in Iranian patients with relapsing–remitting multiple sclerosis (RRMS), supplementing existing clinical evidence from randomized controlled trials. Methods: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Abolfazli, Roya, Sahraian, Mohammad Ali, Tayebi, Atefeh, Kafi, Hamidreza, Samadzadeh, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419910/
https://www.ncbi.nlm.nih.gov/pubmed/37568338
http://dx.doi.org/10.3390/jcm12154937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419910/
https://www.ncbi.nlm.nih.gov/pubmed/37568338
http://dx.doi.org/10.3390/jcm12154937

Ejemplares similares